SCHEMBL396167

SCHEMBL396167

c1cn2c(n1)SCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2845833 0.87
SCHEMBL8820221 0.70
SCHEMBL8820228 0.68
SCHEMBL8709037 0.66 USP2 (0.41)
SCHEMBL19822378 0.66 GAA (0.30)
SCHEMBL3457269 0.64
SCHEMBL23770059 0.63 HTR2A (0.36)
SCHEMBL19262389 0.60
SCHEMBL789334 0.58
SCHEMBL3227671 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0970090-B1 SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE KNOLL GMBH (DE) 2002-06-05 EP claimed
EP-0661967-A1 COMBINED VIRUSTATIC ANTIMEDIATOR (COVAM) TREATMENT OF COMMON COLDS CENTER FOR INNOVATIVE TECHNOLOGY (US) 1995-07-12 EP claimed
EP-0533837-A4 INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES SMITHKLINE BEECHAM CORP (US) 1994-11-17 EP claimed
EP-0661967-A4 COMBINED VIRUSTATIC ANTIMEDIATOR (COVAM) TREATMENT OF COMMON COLDS. UNIV VIRGINIA (US) 1994-09-29 EP claimed
EP-0238070-B1 Sulfonylurea compounds, their production and herbicidal use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1993-12-29 EP claimed
WO-1993009764-A1 COMBINED VIRUSTATIC ANTIMEDIATOR (COVAM) TREATMENT OF COMMON COLDS CENTER FOR INNOVATIVE TECHNOLOGY (US) 1993-05-27 WO claimed
EP-0533837-A1 INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1993-03-31 EP claimed
WO-1991019497-A1 INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1991-12-26 WO claimed
US-5017212-A For rice paddies TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-05-21 US claimed
EP-0238070-A2 Sulfonylurea compounds, their production and herbicidal use Takeda Chemical Industries, Ltd. (JP) 1987-09-23 EP claimed
US-20260085048-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF EPIVARIO INC (US) 2026-03-26 US disclosed
EP-4496785-B1 PESTICIDAL AND HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF AG PLENUS LTD (IL) 2025-12-24 EP disclosed
WO-2025245046-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2025-11-27 WO disclosed
US-20250353862-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2025-11-20 US disclosed
US-12441689-B2 ACSS2 inhibitors and methods of use thereof EPIVARIO, INC. (US) 2025-10-14 US disclosed
US-4175127-A ANTIARTHRITIC AGENTS SMITHKLINE CORPORATION (US) 1979-11-20 US disclosed
US-4153706-A ANTIARTHRITIC AGENTS SMITHKLINE CORPORATION (US) 1979-05-08 US disclosed
US-4110460-A ANTIINFLAMMATORY, ANALGESIC METABIO (FR) 1978-08-29 US disclosed
US-4110460-A ANTIINFLAMMATORY, ANALGESIC METABIO (FR) 1978-08-29 US disclosed
US-4110460-A ANTIINFLAMMATORY, ANALGESIC METABIO (FR) 1978-08-29 US disclosed